Details of the Optogenetic System
General Information of This Optogenetic System (OS) | ||||||
---|---|---|---|---|---|---|
OS ID |
OS00546
|
|||||
OS Name |
Light-activated phosphodiesterases
(LAPD)
|
[1], [2], [3] | ||||
Photoreceptor (PR) |
|
|||||
Cofactor | Biliverdin (BV) | |||||
Controlled Protein | Fusion protein | cGMP-dependent 3',5'-cyclic phosphodiesterase | ||||
OS Application Information (1) | ||||||
---|---|---|---|---|---|---|
Mechanism of Action | Comformational change | [ 1] , [ 2] , [ 3] | ||||
Controlled Signal Pathway | Hydrolysis cAMP/cGMP to interfere Ca2+ influx | |||||
Effect | Inhibition | |||||
Application | Optogenetic control cyclic sdenosine monophosphate (cAMP) in mammalian cells | |||||
Note | No exogenous biliverdin was needed and LAPD could not be fully switched off by far-red light | |||||
Light Information | Activation Wavelength | 670 nm | ||||
Process | Reversible | |||||
Deactivation Wavelength | 780 nm | |||||
Activation Time | 10 s | |||||
Deactivation Time | 10 s | |||||
Light Intensity | 500 milliwatts per square centimeter | |||||
Expression Information | Expression Method | Transfection | ||||
Cell Lines | HEK-TM cells | |||||
References |
---|